Showing 17,321 - 17,340 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((a decrease) OR (greatest decrease)) ))', query time: 0.70s Refine Results
  1. 17321

    Table 4_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xls by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  2. 17322

    Table 2_Identification of metabolic pathways modulated by GAM and NGAM in the inhibition of Staphylococcus aureus biofilm formation.xlsx by Amirmohammad Afsharnia (22569827)

    Published 2025
    “…<p>The prevalence of antibiotic-resistant bacterial strains, particularly Staphylococcus aureus, poses a significant threat to global health. The ability of S. aureus to form biofilms reduces the efficacy of antibiotics. …”
  3. 17323

    Image 1_Identification of metabolic pathways modulated by GAM and NGAM in the inhibition of Staphylococcus aureus biofilm formation.jpeg by Amirmohammad Afsharnia (22569827)

    Published 2025
    “…<p>The prevalence of antibiotic-resistant bacterial strains, particularly Staphylococcus aureus, poses a significant threat to global health. The ability of S. aureus to form biofilms reduces the efficacy of antibiotics. …”
  4. 17324

    Data Sheet 1_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.doc by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  5. 17325

    Table 2_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  6. 17326

    Table 2_Elucidating the impact of organic amendments on soil bacterial communities and strawberry yield in North Carolina.xlsx by Tika B. Adhikari (9310247)

    Published 2025
    “…S. A. The main objective of the study was to examine the effects of reduced rates of dried molasses (5.60 t/ha) and mustard meal (2.24 t/ha), a half-rate combination of both, a positive control (Pic Clor 60), and a negative control (no fumigated and no amended) on soil bacterial communities and strawberry yield. …”
  7. 17327

    Table 7_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  8. 17328

    Table 1_Identification of metabolic pathways modulated by GAM and NGAM in the inhibition of Staphylococcus aureus biofilm formation.xlsx by Amirmohammad Afsharnia (22569827)

    Published 2025
    “…<p>The prevalence of antibiotic-resistant bacterial strains, particularly Staphylococcus aureus, poses a significant threat to global health. The ability of S. aureus to form biofilms reduces the efficacy of antibiotics. …”
  9. 17329

    Exploring the effects of COVID-19 on verbal memory function in schizophrenia: Multiple case study and brief literature review by Barbora Keřková (15125926)

    Published 2024
    “…Compared to their matches, COVID-19 positive cases did not show mutually consistent changes in verbal memory performance: one case experienced a significant decline in verbal memory and learning, while the other showed a general normalization of test scores. …”
  10. 17330

    original data.xlsx by Peng Shen (20145351)

    Published 2024
    “…<b>Research Results</b>: The results showed that the levels of inflammatory factors significantly decreased in the blood purification treatment group after treatment, with a notable reduction in hospitalization and ICU stay duration compared to the conventional treatment group. …”
  11. 17331

    Data Sheet 1_Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients.pdf by Maria Delgado-Ortet (8840702)

    Published 2025
    “…Background<p>High-grade serous carcinoma is a highly metastatic disease with a limited longterm disease control from systemic anti-cancer treatment, for which the radiological treatment response assessment metrics are imprecise. …”
  12. 17332

    Table 1_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  13. 17333

    Table 3_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  14. 17334

    Data Sheet 1_Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis.docx by Ningjun Shao (20748705)

    Published 2025
    “…Despite conventional immunosuppressive therapies, refractory anemia remains a significant challenge, with limited strategies targeting inflammation-driven hepcidin dysregulation.…”
  15. 17335

    Supplementary file 1_Elucidating the impact of organic amendments on soil bacterial communities and strawberry yield in North Carolina.pdf by Tika B. Adhikari (9310247)

    Published 2025
    “…S. A. The main objective of the study was to examine the effects of reduced rates of dried molasses (5.60 t/ha) and mustard meal (2.24 t/ha), a half-rate combination of both, a positive control (Pic Clor 60), and a negative control (no fumigated and no amended) on soil bacterial communities and strawberry yield. …”
  16. 17336

    Data Sheet 2_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.docx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  17. 17337

    Table 6_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  18. 17338

    Table 1_Elucidating the impact of organic amendments on soil bacterial communities and strawberry yield in North Carolina.xlsx by Tika B. Adhikari (9310247)

    Published 2025
    “…S. A. The main objective of the study was to examine the effects of reduced rates of dried molasses (5.60 t/ha) and mustard meal (2.24 t/ha), a half-rate combination of both, a positive control (Pic Clor 60), and a negative control (no fumigated and no amended) on soil bacterial communities and strawberry yield. …”
  19. 17339

    Supplemental file for Training alters cytokine and soluble receptor responses by Jeremy Ducharme (20174820)

    Published 2025
    “…Following 1-hour of cycling at their respiratory compensation point, untrained men (n=5) exhibited a significant increase in pro-inflammatory cytokines, including IL-6, TNF-α, IL-1β, CCL2, and VEGFA. …”
  20. 17340

    Table 5_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xls by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”